Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Gerich

Showing results (51-60 of 241) with videos related to

Pageof 25
Sort By:
The Medical Clinics of North America|July 1, 1978
Somatostatin and diabetesR A Rizza, J E Gerich
Mayo Clinic Proceedings|November 1, 1984
Comparison of plasma insulin profiles after subcutaneous administration of insulin by jet spray and conventional needle injection in patients with insulin-dependent diabetes mellitusG B Pehling, J E Gerich
Clinics in Endocrinology and Metabolism|July 1, 1983
Glucose and ketone body kinetics in diabetic ketoacidosisJ M Miles, J E Gerich
Diabetes Research and Clinical Practice|April 6, 1988
Alpha-glucosidase inhibition and timing of preprandial insulin in patients with insulin-dependent diabetes mellitus (IDDM)F P Kennedy, J E Gerich
The Journal of Clinical Endocrinology and Metabolism|February 1, 1979
Persistent effect of sustained hyperglucagonemia on glucose production in manR A Rizza, J E Gerich
Diabetes|July 1, 1986
Occurrence of dawn phenomenon without change in insulin clearance in patients with insulin-dependent diabetes mellitusP J Campbell, J E Gerich
The New England Journal of Medicine|March 22, 1984
The "dawn phenomenon"--a common occurrence in both non-insulin-dependent and insulin-dependent diabetes mellitusG B Bolli, J E Gerich
Diabetes Care|January 1, 1983
Relevance of glucose counterregulatory systems to patients with diabetes: critical roles of glucagon and epinephrineP E Cryer, J E Gerich
Diabetes Care|July 1, 1983
Importance of timing of preprandial subcutaneous insulin administration in the management of diabetes mellitusG D Dimitriadis, J E Gerich
Diabetes Care|May 1, 1984
Prolonged sulfonylurea administration decreases insulin resistance and increases insulin secretion in non-insulin-dependent diabetes mellitus: evidence for improved insulin action at a postreceptor site in hepatic as well as extrahepatic tissuesL J Mandarino, J E Gerich
Pageof 25

Showing results (51-60 of 241) with videos related to

Sort By:
Pageof 25
The Medical Clinics of North America|July 1, 1978
Somatostatin and diabetesR A Rizza, J E Gerich
Mayo Clinic Proceedings|November 1, 1984
Comparison of plasma insulin profiles after subcutaneous administration of insulin by jet spray and conventional needle injection in patients with insulin-dependent diabetes mellitusG B Pehling, J E Gerich
Clinics in Endocrinology and Metabolism|July 1, 1983
Glucose and ketone body kinetics in diabetic ketoacidosisJ M Miles, J E Gerich
Diabetes Research and Clinical Practice|April 6, 1988
Alpha-glucosidase inhibition and timing of preprandial insulin in patients with insulin-dependent diabetes mellitus (IDDM)F P Kennedy, J E Gerich
The Journal of Clinical Endocrinology and Metabolism|February 1, 1979
Persistent effect of sustained hyperglucagonemia on glucose production in manR A Rizza, J E Gerich
Diabetes|July 1, 1986
Occurrence of dawn phenomenon without change in insulin clearance in patients with insulin-dependent diabetes mellitusP J Campbell, J E Gerich
The New England Journal of Medicine|March 22, 1984
The "dawn phenomenon"--a common occurrence in both non-insulin-dependent and insulin-dependent diabetes mellitusG B Bolli, J E Gerich
Diabetes Care|January 1, 1983
Relevance of glucose counterregulatory systems to patients with diabetes: critical roles of glucagon and epinephrineP E Cryer, J E Gerich
Diabetes Care|July 1, 1983
Importance of timing of preprandial subcutaneous insulin administration in the management of diabetes mellitusG D Dimitriadis, J E Gerich
Diabetes Care|May 1, 1984
Prolonged sulfonylurea administration decreases insulin resistance and increases insulin secretion in non-insulin-dependent diabetes mellitus: evidence for improved insulin action at a postreceptor site in hepatic as well as extrahepatic tissuesL J Mandarino, J E Gerich
Pageof 25